EUVIMEDEUVIMED entdecken
Crossref

Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression

Mingze Li, Ruirui Ge, Haidi Zhu, Yuejia Sun, Yantong Li, Xinrong Liu, Yanzhi Song iD, Yihui Deng iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Mingze Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China. Hauptthemen laut MEDLINE: Nanoparticles, N-Acetylneuraminic Acid, Lung Neoplasms, Hydroxyquinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic homeostasis is integral to the development of malignant tumors. Combining epigenetic drugs with chemotherapy is a promising strategy to overcome the challenges in treating lung metastasis from melanoma. In this study, we constructed sialic acid-modified ibrutinib-phospholipid complex nanoparticles (SA-IBR-NPs) to actively target and deliver the drug to lung metastasis sites through the mononuclear phagocytic system (MPS) pathway. A highly soluble 5-Carboxy-8-hydroxyquinoline-arginine salt (IOX1-Arg) was also developed to inhibit tumor cells' intrinsic immune escape mechanisms. The combined administration of IOX1-Arg and SA-IBR-NPs significantly reduced the migration and invasion abilities of B16F10 cells and inhibited lung metastasis. The number of tumor nodules in experimental groups (including single-agent treatment groups, non-SA-modified nanoparticle groups, and non-IOX1-Arg combined groups) was 3.67-28.00 times higher than that of the IOX1-Arg + SA-IBR-NPs. The malignant index of tumor metastasis in single therapy or plain nanoparticle groups was 5.38-1062.29 times higher than that of the IOX1-Arg + SA-IBR-NP treatments, as well. This combination therapy also increased the levels of cytotoxic T cells. The antitumor immune response was effectively restructured by blocking the intrinsic escape mechanism of tumor cells and simultaneously inhibiting the immunosuppressive factors in the microenvironment. This strategy presents a novel approach to enhancing targeted therapy for metastatic tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesN-Acetylneuraminic AcidLung NeoplasmsHydroxyquinolinesAnimalsMiceCell Line, TumorMice, Inbred C57BLMelanoma, ExperimentalHumansTumor EscapeCell Movement

Stichwörter der Autor:innen

combined therapyepigeneticsphospholipid complex nanoparticlessialic acidtumor

Substanzen

N-Acetylneuraminic AcidHydroxyquinolines

Autor:innen und Institutionen

  • College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.

ORCID-Profile: Yanzhi Song, Yihui Deng

Zitieren

APA

Li, M., Ge, R., Zhu, H., Sun, Y., Li, Y., Liu, X., Song, Y., & Deng, Y. (2026). Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01117

Vancouver

Li M, Ge R, Zhu H, Sun Y, Li Y, Liu X, et al. Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01117

BibTeX
@article{Li2026,
  author = {Li, Mingze and Ge, Ruirui and Zhu, Haidi and Sun, Yuejia and Li, Yantong and Liu, Xinrong and Song, Yanzhi and Deng, Yihui},
  title = {Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01117}
}
Kostenlos starten →